Lift Biosciences

Developer of neutrophil-based cell therapies for solid tumors

placeLondon, England, United Kingdom calendar_todayFounded 2016 groups8 employees language liftbiosciences.com

Registered entities

Innovation

14 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 618 times.

YearFilings
20161
20181
20191
20203
20213
20223
20237
20247
20252
20265

Social engagement

Social engagement: 3.6K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record; lead investors include MassChallenge, Downing, Kizoo, LifeSpan Vision Ventures.

Investor typeCountShare
Venture capital213%
Private equity17%
Accelerator & incubator320%
Other / undisclosed960%

Recent activity

7 Jan 2026
Leadership hire
Interim Chief Executive Officer
18 Nov 2025
Recognition
6 Nov 2025
Event
40th Society for Immunotherapy of Cancer (SITC) Annual Conference
Coming soon